Anhydroretinol and derivatives thereof as antagonists of immune responses and inhibitors of cancer cell growth


Ontology type: sgo:Patent     


Patent Info

DATE

1999-03-16T00:00

AUTHORS

Ulrich Hammerling , Jochen Buck , Fadila Derguini , Koji Nakanishi

ABSTRACT

This invention provides methods of inhibiting the growth of cells, of treating a subject having a disease characterized by an uncontrolled growth of cells and of blocking an immune response as well as related inflammatory responses in a subject which comprises administering a compound having the structure: ##STR1##

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2581", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "Ulrich Hammerling", 
        "type": "Person"
      }, 
      {
        "name": "Jochen Buck", 
        "type": "Person"
      }, 
      {
        "name": "Fadila Derguini", 
        "type": "Person"
      }, 
      {
        "name": "Koji Nakanishi", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1084/jem.171.5.1613", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005997088"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1084/jem.176.1.109", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015366056"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0168-9525(88)90108-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018233757"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0168-9525(88)90108-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018233757"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1083/jcb.115.3.851", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031444679"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/268154a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035554707", 
          "https://doi.org/10.1038/268154a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0091-7435(89)90034-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038681741"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.84.5.1374", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050572688"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.3283939", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062604293"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1999-03-16T00:00", 
    "description": "

This invention provides methods of inhibiting the growth of cells, of treating a subject having a disease characterized by an uncontrolled growth of cells and of blocking an immune response as well as related inflammatory responses in a subject which comprises administering a compound having the structure: ##STR1##

", "id": "sg:patent.US-5883136-A", "keywords": [ "derivative", "antagonist", "immune response", "inhibitor", "cancer cell growth", "invention", "method", "cell", "disease", "uncontrolled growth", "inflammatory response", "compound" ], "name": "Anhydroretinol and derivatives thereof as antagonists of immune responses and inhibitors of cancer cell growth", "recipient": [ { "id": "https://www.grid.ac/institutes/grid.21729.3f", "type": "Organization" }, { "id": "https://www.grid.ac/institutes/grid.51462.34", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/US-5883136-A" ], "sdDataset": "patents", "sdDatePublished": "2019-04-18T10:26", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-uberresearch-data-patents-target-20190320-rc/data/sn-export/402f166718b70575fb5d4ffe01f064d1/0000100128-0000352499/json_export_03054.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.US-5883136-A'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.US-5883136-A'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.US-5883136-A'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.US-5883136-A'


 

This table displays all metadata directly associated to this object as RDF triples.

76 TRIPLES      15 PREDICATES      36 URIs      20 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.US-5883136-A schema:about anzsrc-for:2581
2 anzsrc-for:3103
3 schema:author N678dc71d2bbc44a2a84e036856d310a6
4 schema:citation sg:pub.10.1038/268154a0
5 https://doi.org/10.1016/0091-7435(89)90034-0
6 https://doi.org/10.1016/0168-9525(88)90108-4
7 https://doi.org/10.1073/pnas.84.5.1374
8 https://doi.org/10.1083/jcb.115.3.851
9 https://doi.org/10.1084/jem.171.5.1613
10 https://doi.org/10.1084/jem.176.1.109
11 https://doi.org/10.1126/science.3283939
12 schema:datePublished 1999-03-16T00:00
13 schema:description <p>This invention provides methods of inhibiting the growth of cells, of treating a subject having a disease characterized by an uncontrolled growth of cells and of blocking an immune response as well as related inflammatory responses in a subject which comprises administering a compound having the structure: ##STR1##</p>
14 schema:keywords antagonist
15 cancer cell growth
16 cell
17 compound
18 derivative
19 disease
20 immune response
21 inflammatory response
22 inhibitor
23 invention
24 method
25 uncontrolled growth
26 schema:name Anhydroretinol and derivatives thereof as antagonists of immune responses and inhibitors of cancer cell growth
27 schema:recipient https://www.grid.ac/institutes/grid.21729.3f
28 https://www.grid.ac/institutes/grid.51462.34
29 schema:sameAs https://app.dimensions.ai/details/patent/US-5883136-A
30 schema:sdDatePublished 2019-04-18T10:26
31 schema:sdLicense https://scigraph.springernature.com/explorer/license/
32 schema:sdPublisher N3cce1151c3564c6d8f1de2d9e6dc771c
33 sgo:license sg:explorer/license/
34 sgo:sdDataset patents
35 rdf:type sgo:Patent
36 N21c445bd7950496ba26e29600b9c1398 schema:name Ulrich Hammerling
37 rdf:type schema:Person
38 N3cce1151c3564c6d8f1de2d9e6dc771c schema:name Springer Nature - SN SciGraph project
39 rdf:type schema:Organization
40 N481ef80002c742d6bb0e1a6816077f7e rdf:first N5b0036ba87b7480697a57fdb976f8f4d
41 rdf:rest N5ab7a171ca6c4a29a51c39d26c906c9b
42 N5ab7a171ca6c4a29a51c39d26c906c9b rdf:first Nf091a6b73e45404e986c74181016424d
43 rdf:rest rdf:nil
44 N5b0036ba87b7480697a57fdb976f8f4d schema:name Fadila Derguini
45 rdf:type schema:Person
46 N61c2a7e8db2b48f788388f2e20b51fc4 schema:name Jochen Buck
47 rdf:type schema:Person
48 N678dc71d2bbc44a2a84e036856d310a6 rdf:first N21c445bd7950496ba26e29600b9c1398
49 rdf:rest N683b8dbb62ed43e182762e9c7f16a632
50 N683b8dbb62ed43e182762e9c7f16a632 rdf:first N61c2a7e8db2b48f788388f2e20b51fc4
51 rdf:rest N481ef80002c742d6bb0e1a6816077f7e
52 Nf091a6b73e45404e986c74181016424d schema:name Koji Nakanishi
53 rdf:type schema:Person
54 anzsrc-for:2581 schema:inDefinedTermSet anzsrc-for:
55 rdf:type schema:DefinedTerm
56 anzsrc-for:3103 schema:inDefinedTermSet anzsrc-for:
57 rdf:type schema:DefinedTerm
58 sg:pub.10.1038/268154a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035554707
59 https://doi.org/10.1038/268154a0
60 rdf:type schema:CreativeWork
61 https://doi.org/10.1016/0091-7435(89)90034-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038681741
62 rdf:type schema:CreativeWork
63 https://doi.org/10.1016/0168-9525(88)90108-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018233757
64 rdf:type schema:CreativeWork
65 https://doi.org/10.1073/pnas.84.5.1374 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050572688
66 rdf:type schema:CreativeWork
67 https://doi.org/10.1083/jcb.115.3.851 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031444679
68 rdf:type schema:CreativeWork
69 https://doi.org/10.1084/jem.171.5.1613 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005997088
70 rdf:type schema:CreativeWork
71 https://doi.org/10.1084/jem.176.1.109 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015366056
72 rdf:type schema:CreativeWork
73 https://doi.org/10.1126/science.3283939 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062604293
74 rdf:type schema:CreativeWork
75 https://www.grid.ac/institutes/grid.21729.3f schema:Organization
76 https://www.grid.ac/institutes/grid.51462.34 schema:Organization
 




Preview window. Press ESC to close (or click here)


...